HSPB6 and dilated cardiomyopathy: The relevance of this regulatory mechanism to heart disease pathogenesis is further underscored by the molecular and cellular implications of the phosphorylation impairing Hsp20-P20L mutation that has been observed in dilated cardiomyopathy patients [13,53].